not tagged
not tagged
[]
evolut trial -&gt; 3 year outcomes severe as + low risk -&gt; anatomy suitable for both tavr and savr 7.4 % all cause mortality + cva in tavr vs 10.4% in savr paravalvular regurg none to trace 80% in tavr valve hemodynamics tavr &gt; savr #acc23 #wcc #accearlycareer 
Cardiologist, Advanced/Structural Imaging, @scrippshealth @uconnhealth @drexelmedicine  #wim #accwic #accearlycareer Opinions are my own